Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine versus placebo crossover study of driving performance and EEG in adults with ADHD
NL-OMON31557Withdrawn
- Sponsor
- Utrecht University
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Double-blind trial of atomoxetine in attention deficit hyperactivity disorder (ADHD), sponsored by Utrecht University. Planned start Jul 2008; status: withdrawn.
02
Drugs
atomoxetine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NL-OMON31557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31557.